SAINT® clinical trials

SAINT is indicated for the treatment of adults with major depressive disorder (MDD) who have failed to achieve satisfactory improvement from prior antidepressant medication. Clinical trials are ongoing to evaluate SAINT for additional neuropsychiatric conditions. Those conditions are not cleared by the FDA.

PPD
Magnus Medical
A Randomized Controlled Multi-Site Trial Evaluating SAINT for Postpartum Depression
RECRUITING
MDD
Magnus Medical
An Open Label Optimization Study to Assess the Effectiveness of the SAINT Neuromodulation System (NMS) to Treat Major Depressive Disorder
ACTIVE, NOT RECRUITING
MDD Magnus Medical
An Open Label Pilot Trial to Assess the Feasibility of Using the Magnus Neuromodulation System (MNS) with SAINT as a Maintenance Treatment for Depression

COMPLETED

TRD Investigator
Psilocybin rTMS for Treatment Resistant Depression (PSILOBSD)

RECRUITING

MDD Investigator
Accelerated Intermittent Theta Burst in Treatment-Naive Adolescents (SAINT-KID)

RECRUITING

MDD Magnus Medical
An Open Label Optimization Study to Assess the Effectiveness of the SAINT Neuromodulation System (NMS) to Treat Major Depressive Disorder

ACTIVE, NOT RECRUITING

PPD Magnus Medical
A Randomized Controlled Multi-Site Trial Evaluating SAINT for Postpartum Depression

RECRUITING

Bring SAINT® to your practice

Become a Verified SAINT Provider today.

Contact us
Find a provider